However, the authors also assert that nonadherence is the "greatest obstacle to recovery and relapse prevention" (emphasis ours). It may seem logically obvious that lack of relapse is a precondition for recovery, but this may not be so. If by recovery we mean functional recovery (e.g., the capacity to work, have meaningful relationships, and have a satisfying life), positive symptoms have less relevance than cognitive and negative symptoms. Antipsychotics do little, if anything, to help these crucial factors, but they do have serious toxicities that increase morbidity and mortality. Their overall impact is such that patients routinely discontinue them (2). One of the great drivers of nonadherence in schizophrenia may be that many patients want recovery rather than a reduction in positive symptoms; psychiatrists who view clinical outcomes primarily as positive symptom control emphasize compliance.